Quick answer: Without insurance, an FDA-approved GLP-1 costs $149 to $499 a month at the makers' own self-pay pharmacies, depending on the drug and dose. List prices run $649 to $1,349.02. Averaged over a first year, that is about $266 to $499 a month (our arithmetic). Prices checked Oct 20, 2026 on NovoCare and LillyDirect.
- Pills: Wegovy pill and Foundayo from $149/mo; Ozempic pill (type 2 diabetes) from $149.
- Weekly injections: Wegovy and Ozempic pens $349/mo, Zepbound $299 to $449, Mounjaro $499.
- With commercial insurance: savings cards from $25. On Medicare Part D: $50/mo through the GLP-1 Bridge, if eligible.
- Compounded semaglutide or tirzepatide: $99 to $432/mo all-in. Not FDA-approved.
GLP-1 cost without insurance by drug (October 2026)
Each GLP-1 has three prices: the list price the maker sets, the maker's own cash price, and what discounts or savings programs bring it to. The last column averages a first year, because most of these drugs get more expensive as the dose goes up.
| Drug | List price | Self-pay per month (maker's pharmacy) | Cash-pay discounts and savings programs | Average per month, year one |
|---|---|---|---|---|
| Wegovy pill FDA-approved oral semaglutide · Daily pill · Weight management |
$1,349.02 per package | $149 at 1.5 mg, $199 at 4 mg, $299 at 9 and 25 mg | With commercial coverage: as little as $25/mo (savings capped at $100/mo) | $278 $3,338 a year: 1.5, 4 and 9 mg for a month each, then 25 mg. Source: NovoCare Wegovy, checked Oct 20, 2026 |
| Wegovy pen FDA-approved semaglutide · Weekly injection · Weight management |
$1,349.02 per package | $349 from 0.25 to 2.4 mg; $399 at 7.2 mg | New patients: $199 for the first 2 fills at 0.25 or 0.5 mg (through Dec 31, 2026). With commercial coverage: as little as $25/mo (savings capped at $100/mo) | $349 $4,188 a year: one price from 0.25 to 2.4 mg; $3,888 with the new-patient offer. Source: NovoCare Wegovy, checked Oct 20, 2026 |
| Ozempic pill FDA-approved oral semaglutide · Daily pill · Type 2 diabetes |
$1,027.51 per package | $149 at 1.5 mg, $199 at 4 mg, $299 at 9 mg | Savings-card terms for the pill not checked here | $278 $3,338 a year: 1.5 and 4 mg for a month each, then 9 mg. Source: NovoCare Ozempic price guide, list price, checked Oct 20, 2026 |
| Ozempic pen FDA-approved semaglutide · Weekly injection · Type 2 diabetes |
$1,027.51 per pen | $349 at 0.25, 0.5 and 1 mg; $499 at 2 mg | New patients: $199 for the first 2 fills at 0.25 or 0.5 mg (through Dec 31, 2026). With commercial coverage: as little as $25/mo (savings capped at $100/mo) | $349 $4,188 a year: one price from 0.25 to 1 mg. Source: NovoCare Ozempic price guide, list price, checked Oct 20, 2026 |
| Zepbound FDA-approved tirzepatide · Weekly injection (vial or KwikPen) · Weight management; sleep apnea with obesity |
$499–$1,086.37 per fill | $299 at 2.5 mg, $399 at 5 mg, $449 at 7.5 to 15 mg if refilled within 45 days ($499–$699 otherwise) | With commercial coverage: as little as $25 for up to a 3-month fill (savings capped at $100 per monthly fill) | $432 $5,188 a year: 2.5 and 5 mg for a month each, then 7.5 mg. Source: LillyDirect Zepbound, list price, savings, checked Oct 20, 2026 |
| Mounjaro FDA-approved tirzepatide · Weekly injection (single-dose pen) · Type 2 diabetes |
$1,112.16 per fill | $499 at every dose, 2.5 to 15 mg | With commercial coverage: as little as $25 for up to a 3-month fill (card pays up to $150/mo) | $499 $5,988 a year: one price at every dose (12 fills). Source: LillyDirect Mounjaro, list price, savings, checked Oct 20, 2026 |
| Foundayo FDA-approved orforglipron · Daily pill · Weight management |
$649.00 per 30 days | $149 at 0.8 mg, $149 at 2.5 mg, $199 at 5.5 mg, $299 at 9 mg and up | The 2.5 and 5.5 mg prices are promotional through Dec 31, 2026. With commercial coverage: as little as $25/mo | $266 $3,188 a year: 0.8, 2.5 and 5.5 mg for a month each, then 9 mg ($3,338 once the promo prices end). Source: LillyDirect Foundayo, list price, checked Oct 20, 2026 |
| Compounded semaglutide Compounded, not FDA-approved Weekly injection · 503A or 503B pharmacy |
None | $99–$324 all-in at the starting dose (15 sellers) | Prepaid plans: $99–$197/mo on 12 months; month to month $99–$324. No savings cards | Depends on the seller and plan Source: each seller's own page, in our compounded semaglutide cost table, checked Oct 20, 2026 |
| Compounded tirzepatide Compounded, not FDA-approved Weekly injection · 503A or 503B pharmacy |
None | $125–$432 all-in at the starting dose (13 sellers) | Prepaid plans: $125–$240/mo on 12 months; month to month $129–$432. No savings cards | Depends on the seller and plan Source: each seller's own page, in our compounded tirzepatide cost table, checked Oct 20, 2026 |
Ozempic and Mounjaro are FDA-approved for type 2 diabetes, not weight management. Lilly's list-price pages (pricinginfo.lilly.com) show a bot check to automated readers, so Lilly's list prices are as Lilly's pages appear in Google's results on Oct 20, 2026. Novo Nordisk says it will cut the Wegovy and Ozempic list price to $675 a month from Jan 1, 2027 and that its self-pay prices will not change (Novo Nordisk announcement). The pharmacy's checkout is the final word on price.
How much is a GLP-1 per month without insurance?
It depends on the drug more than anything else. At the starting dose, a GLP-1 pill costs $149 a month and a weekly injection $299 to $499. Over a year the gap narrows or widens with the dose steps:
- Foundayo: $3,188 a year, about $266 a month, while the 2.5 and 5.5 mg promo prices last ($3,338 after Dec 31, 2026).
- Wegovy pill: $3,338 a year, about $278 a month: it reaches $299 by the third month.
- Wegovy or Ozempic pen: $4,188 a year at $349 a month, the same at every dose up to 2.4 mg (Wegovy) or 1 mg (Ozempic).
- Zepbound: $5,188 a year, about $432 a month, if each refill comes within 45 days.
- Mounjaro: $5,988 for 12 fills at $499; a 28-day fill means 13 fills a year in practice. See Mounjaro cost without insurance.
These are medication only. The prescriber visit, and any telehealth membership, comes on top. Your prescriber sets your dose, so your own year may differ.
4 ways to pay for a GLP-1 without insurance
- The maker's own pharmacy. NovoCare Pharmacy (Wegovy, Ozempic) and LillyDirect (Zepbound, Mounjaro, Foundayo) sell at the self-pay prices in the table to anyone with a valid prescription. No insurance is billed, and the purchase does not count toward a deductible.
- A telehealth membership that prescribes the brand drug. Platforms such as Ro, Hims, Hers and LifeMD add a monthly membership on top of the maker's price; see the totals, seller by seller, in our GLP-1 price comparison ranked by monthly cost.
- A retail pharmacy cash price. Usually the most expensive way to pay. Discount-card sites estimated Mounjaro at about $1,519 (SingleCare, June 3, 2026) to over $1,300 a month (GoodRx, June 9, 2026), against $499 from LillyDirect. Ask your pharmacy before you fill.
- Compounded semaglutide or tirzepatide. Sold through telehealth companies for less, but not FDA-approved. See the compounded section below.
GLP-1 savings cards: what they do with and without insurance
- Wegovy and Ozempic: with commercial insurance that covers the drug, Novo Nordisk's savings offer can bring a month to as little as $25, with savings capped at $100 a month (NovoCare).
- Zepbound single-dose pen and Mounjaro: with commercial coverage, Lilly's cards can bring a 1-, 2- or 3-month fill to as little as $25; the cap is $100 per monthly fill for Zepbound and $150 for Mounjaro (Zepbound savings, Mounjaro savings). The Mounjaro card ends Dec 31, 2026.
- Foundayo: with commercial coverage, as little as $25 a month (Foundayo savings).
- No insurance at all: the cards do not apply. The cash-pay discounts that do apply are the makers' own: NovoCare's $199 first two fills of the Wegovy or Ozempic pen for new patients, Foundayo's promo prices at 2.5 and 5.5 mg, and Zepbound's $449 price when you refill within 45 days.
The savings cards cannot be used with Medicare or Medicaid; Lilly's also exclude TRICARE, VA and other government plans. If your plan excludes weight-loss drugs, see how to get a GLP-1 covered by insurance. Prescribed medication can be a medical expense for an HSA or FSA under IRS Publication 502; see using HSA or FSA money for a GLP-1.
Medicare GLP-1 Bridge: $50 a month
From July 1, 2026 to Dec 31, 2027, eligible Medicare Part D members pay a flat $50 a month for Wegovy, the Zepbound KwikPen or Foundayo for weight management (CMS: Medicare GLP-1 Bridge, checked Oct 20, 2026). Eligibility follows CMS clinical criteria, roughly a BMI of 35 or more, or lower with certain heart or metabolic conditions. Separately, many Part D plans cover Ozempic and Mounjaro for type 2 diabetes. Medicaid coverage is set by each state.
Compounded GLP-1 cost without insurance (not FDA-approved)
Telehealth companies sell compounded semaglutide for $99 to $324 a month and compounded tirzepatide for $125 to $432, all-in at the starting dose, across the 15 and 13 sellers in our dated tables (checked Oct 20, 2026). The lowest of those prices usually need a prepaid plan. Seller by seller: compounded semaglutide cost and compounded tirzepatide cost.
Compounded semaglutide and tirzepatide are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality before they are sold, and it has received reports of dosing errors with compounded GLP-1s (FDA's concerns with unapproved GLP-1 drugs, content current as of Oct 1, 2026). They are not generic versions and are not the same products as Wegovy, Ozempic, Zepbound or Mounjaro. No savings card or Medicare program covers them.
Frequently asked questions
How much is a GLP-1 without insurance?
An FDA-approved GLP-1 costs $149 to $499 a month without insurance at the makers' own self-pay pharmacies, depending on the drug and dose, against list prices of $649 to $1,349.02 (checked Oct 20, 2026). Compounded semaglutide and tirzepatide are listed at $99 to $432 a month all-in but are not FDA-approved.
How much does a GLP-1 cost per month without insurance?
At the starting dose: $149 for Foundayo or the Wegovy pill, $349 for the Wegovy or Ozempic pen ($199 for a new patient's first two fills), $299 for Zepbound and $499 for Mounjaro, medication only (checked Oct 20, 2026). Most of these rise with the dose; Mounjaro and the Wegovy pen (up to 2.4 mg) do not.
What is the average cost of a GLP-1 without insurance?
Averaged over a first year of label dose steps, our arithmetic puts it at about $266 a month for Foundayo, $278 for the Wegovy pill, $349 for the Wegovy pen, $432 for Zepbound and $499 for Mounjaro. A prescriber visit is extra.
What is the price of Mounjaro?
Mounjaro is $499 a month at every dose through LillyDirect self-pay, against a list price of $1,112.16 per fill of 4 pens. With commercial insurance that covers it, Lilly's savings card can bring it to as little as $25.
How much are GLP-1 pills without insurance?
The Wegovy pill and Foundayo both start at $149 a month self-pay and reach $299 at higher doses, and the Ozempic pill, approved for type 2 diabetes, is $149 to $299 (checked Oct 20, 2026). Compounded tablets are sometimes sold for less but are not FDA-approved.
How much is a GLP-1 per year without insurance?
Our arithmetic for a first year at today's self-pay prices: $3,188 for Foundayo, $3,338 for the Wegovy pill, $4,188 for the Wegovy pen, $5,188 for Zepbound and $5,988 for Mounjaro. Add the prescriber's fees.
Can I get a GLP-1 for $25 without insurance?
No. The $25 prices need commercial insurance that covers the drug plus the maker's savings card; without insurance, the lowest FDA-approved self-pay price is $149 a month.
How to get a GLP-1 prescription?
From any licensed prescriber, in person or by telehealth, who decides you meet the label criteria, generally a BMI of 30 or more, or 27 or more with a weight-related condition. NovoCare Pharmacy and LillyDirect fill the prescription; they do not write it.
Is semaglutide covered by insurance?
It depends on the plan and the use: Ozempic is approved for type 2 diabetes and Wegovy for weight management, and many commercial plans still exclude weight-loss drugs, so check your formulary and ask about prior authorization. Eligible Medicare Part D members can get Wegovy for $50 a month through the Medicare GLP-1 Bridge until Dec 31, 2027.
How much is a GLP-1 with Medicare?
Through the Medicare GLP-1 Bridge, eligible Part D members pay $50 a month for Wegovy, the Zepbound KwikPen or Foundayo from July 1, 2026 to Dec 31, 2027. The makers' savings cards cannot be used with Medicare or Medicaid.
Is compounded GLP-1 cheaper than brand-name?
Often: compounded semaglutide runs $99 to $324 and compounded tirzepatide $125 to $432 a month all-in in our tables, many on prepaid plans, against $149 to $499 for brand self-pay. Compounded GLP-1s are not FDA-approved and are not the same products as Wegovy or Zepbound.
Can you use HSA or FSA money for a GLP-1?
Usually, when the drug is prescribed to treat a medical condition, since prescribed medication can be a qualified medical expense; LillyDirect, for example, lists Mounjaro self-pay as FSA/HSA eligible, varying by plan. Check with your plan administrator.
Sources and references
- NovoCare: Wegovy pill and pen self-pay and list prices, savings offer (checked Oct 20, 2026)
- NovoCare: Ozempic pill and pen price guide (checked Oct 20, 2026) and Ozempic list price (checked Oct 20, 2026)
- Novo Nordisk: Wegovy and Ozempic list price to $675 a month from Jan 1, 2027
- LillyDirect: Zepbound self-pay prices, list price and savings card (checked Oct 20, 2026)
- LillyDirect: Mounjaro self-pay price, list price and savings card (checked Oct 20, 2026)
- LillyDirect: Foundayo self-pay prices, list price and savings (checked Oct 20, 2026)
- CMS: Medicare GLP-1 Bridge (checked Oct 20, 2026)
- SingleCare: Mounjaro without insurance (updated June 3, 2026) and GoodRx: Mounjaro without insurance (updated June 9, 2026), third-party estimates
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss (content current as of Oct 1, 2026) and FDA: Human drug compounding
- IRS Publication 502: Medical and Dental Expenses
- Compounded prices: each seller's own page, linked in our compounded cost tables (checked Oct 20, 2026)
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Zepbound®, Mounjaro® and Foundayo™ are trademarks of Eli Lilly and Company. Nouri is not affiliated with either maker. Nouri is a publisher; it does not prescribe or sell any medication. Not medical, financial or tax advice: a licensed prescriber decides whether a GLP-1 fits you. Compounded semaglutide and tirzepatide are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality.
Disclosure: Nouri may earn a commission when you sign up with some of the providers we link to. It doesn't change what you pay or how we rank providers. No price on this page pays Nouri. Full disclosure.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Nouri is an independent publisher: it does not prescribe, review patient assessments, or sell medication. Talk to a licensed clinician before starting or changing any medication or treatment.
Compare licensed GLP-1 providers
Published cash prices side by side, with the month we checked them and a link to each provider's own site. Nouri doesn't prescribe or sell medication.